CD9 and acute myeloid leukemia: Except for TP53-mutated AMLs, leukemic blasts demonstrated a tendency for a higher CD9 GMFI as compared to normal myeloid blasts with APL, AML with CBFB::MYH11, and AML with KMT2Ar expressing the highest levels (Figure 4, Figures S2 and S3).